T1	Participants 63 106	25 patients with advanced esophageal cancer
T2	Participants 206 272	patients came from the hospitals of the cooperative research group
T3	Participants 420 505	22 cases were squamous cell carcinoma, 1 adenocarcinoma and 2 squamous adenocarcinoma
